Leucogenics Company

The purpose of the Leucogenics is the research, development and marketing of immunosuppressive therapies and diagnoses. Leucogenics may acquire, manage and sell real estate as well as any business directly or indirectly related to the purpose of the Company. The company also participates in other, domestic or foreign companies of all kinds.
Technology: Precision Medicine
Industry: P3 Medicine
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2009
Employees Number: Undisclosed
Funding Status: Undisclosed

Register and Claim Ownership